Evelo Biosciences

-$0.60 (-6.02%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EVLO and other ETFs, options, and stocks.

About EVLO

Evelo Biosciences, Inc. operates as a clinical stage biotechnology company, which engages in the development of orally delivered investigational medicines. Its portfolio includes EDP1066 and EDP1815 for the treatment of inflammatory diseases; EDP2939 for inflammation; and EDP1908 for oncology.

CEO
Balkrishan Gill
Employees
90
Headquarters
Cambridge, Massachusetts
Founded
2014

EVLO Key Statistics

Market Cap
732.36M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
266.65K
High Today
$9.92
Low Today
$9.29
Open Price
$9.87
Volume
258.46K
52 Week High
$19.93
52 Week Low
$3.65

EVLO Earnings

-$0.78
-$0.52
-$0.26
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
-$0.54 per share
Actual
Available Jul 29, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure